Andover House, Inc. (ANHI) is a scholarly journal publisher focusing on the online dissemination of academic journals that are open to the scientific community and accessible to the public without additional charges to readers and libraries.
Founded in January 2018, ANHI is a not-for-profit publisher registered in the Commonwealth of Massachusetts, USA, and as a 501(3)c public charity, EIN 82-4239886.
The aim and scope of Andover House Inc. is to provide good quality and supportive publishing forum with quick turnaround time for nanomedicine researchers and offer a cutting-edge and reliable information source to societies, libraries, and the interested public without additional cost.
Our objective is to publish peer-reviewed scientific reports and individual articles online in academic journals that are open to the scientific community and accessible by the public without additional charge to readers and libraries.
Our mission is further the progress of science, engineering, and technology in medicine and promote all progressive and rational aspects of nanomedicine from basic science through commercialization while exercising good publishing practice.
We support authors who wish to share their work early through the deposition of manuscripts with preprint servers such as bioRxiv or arXiv, research that has been presented at conferences, published as a thesis, or have previously appeared in other “non-journal” venues (for example, blogs or posters).
All articles receive a unique identifier and are archived in Portico for preservation. Article DOI-s may be searched in Crossref and DOAJ. We are members of COPE and DOAJ; our green archiving policy is registered in Sherpa/Romeo, so both preprint and post-print PDFs (as well as Publisher’s versions) can be archived without restrictions. Authors are responsible for updating the archived preprint with the journal reference (including DOI) and a link to the published articles on the appropriate journal website upon publication.
The Publisher is governed by the Board of Directors, which oversees operations, approves the annual budget, and sets strategic goals for the organization. We are supported by the European Foundation for Clinical Nanomedicine, the International Society for Nanomedicine and by the European Society for Nanomedicine
NOTE: We are signatories of the San Francisco Declaration on Research Assessment. We advise against the use of journal-based metrics, such as Journal Impact Factors, as a surrogate measure of individual research articles’ quality to assess an individual scientist’s contributions or in hiring, promotion, or funding decisions. We support article-based metrics and follow the publication policies of WHO, COPE, and ICMJE.